These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 15621170)
1. Impact of donor immune cells in pancreatic islet transplantation. Carter JD; Chen M; Ellett JD; Smith KM; Nadler JL; Yang Z Transplant Proc; 2004 Nov; 36(9):2866-8. PubMed ID: 15621170 [TBL] [Abstract][Full Text] [Related]
2. Viral IL-10-mediated immune regulation in pancreatic islet transplantation. Carter JD; Ellett JD; Chen M; Smith KM; Fialkow LB; McDuffie MJ; Tung KS; Nadler JL; Yang Z Mol Ther; 2005 Aug; 12(2):360-8. PubMed ID: 16043104 [TBL] [Abstract][Full Text] [Related]
3. Abrogation of recurrent autoimmunity in the NOD mouse: A critical role for host interleukin 4. Shi Q; Wang D; Hadley GA; Farber DL; Bartlett ST Surgery; 2006 Aug; 140(2):281-8. PubMed ID: 16904981 [TBL] [Abstract][Full Text] [Related]
4. Gene transfection and expression of transforming growth factor-beta1 in nonobese diabetic mouse islets protects beta-cells in syngeneic islet grafts from autoimmune destruction. Suarez-Pinzon WL; Marcoux Y; Ghahary A; Rabinovitch A Cell Transplant; 2002; 11(6):519-28. PubMed ID: 12428741 [TBL] [Abstract][Full Text] [Related]
5. TNF-alpha down-regulates type 1 cytokines and prolongs survival of syngeneic islet grafts in nonobese diabetic mice. Rabinovitch A; Suarez-Pinzon WL; Sorensen O; Rajotte RV; Power RF J Immunol; 1997 Dec; 159(12):6298-303. PubMed ID: 9550435 [TBL] [Abstract][Full Text] [Related]
6. A new type of CD4+ suppressor T cell completely prevents spontaneous autoimmune diabetes and recurrent diabetes in syngeneic islet-transplanted NOD mice. Han HS; Jun HS; Utsugi T; Yoon JW J Autoimmun; 1996 Jun; 9(3):331-9. PubMed ID: 8816968 [TBL] [Abstract][Full Text] [Related]
7. Anti-CD20 treatment prolongs syngeneic islet graft survival and delays the onset of recurrent autoimmune diabetes. Hu C; Deng S; Wong FS; Wen L Ann N Y Acad Sci; 2008 Dec; 1150():217-9. PubMed ID: 19120299 [TBL] [Abstract][Full Text] [Related]
8. Indefinite islet protection from autoimmune destruction in nonobese diabetic mice by agarose microencapsulation without immunosuppression. Kobayashi T; Aomatsu Y; Iwata H; Kin T; Kanehiro H; Hisanaga M; Ko S; Nagao M; Nakajima Y Transplantation; 2003 Mar; 75(5):619-25. PubMed ID: 12640299 [TBL] [Abstract][Full Text] [Related]
9. Local expression of immunoregulatory IL-12p40 gene prolonged syngeneic islet graft survival in diabetic NOD mice. Yasuda H; Nagata M; Arisawa K; Yoshida R; Fujihira K; Okamoto N; Moriyama H; Miki M; Saito I; Hamada H; Yokono K; Kasuga M J Clin Invest; 1998 Nov; 102(10):1807-14. PubMed ID: 9819366 [TBL] [Abstract][Full Text] [Related]
10. Costimulation blockade of both inducible costimulator and CD40 ligand induces dominant tolerance to islet allografts and prevents spontaneous autoimmune diabetes in the NOD mouse. Nanji SA; Hancock WW; Luo B; Schur CD; Pawlick RL; Zhu LF; Anderson CC; Shapiro AM Diabetes; 2006 Jan; 55(1):27-33. PubMed ID: 16380473 [TBL] [Abstract][Full Text] [Related]
11. Long-term islet allograft survival in nonobese diabetic mice treated with tacrolimus, rapamycin, and anti-interleukin-2 antibody. Molano RD; Pileggi A; Berney T; Poggioli R; Zahr E; Oliver R; Malek TR; Ricordi C; Inverardi L Transplantation; 2003 Jun; 75(11):1812-9. PubMed ID: 12811239 [TBL] [Abstract][Full Text] [Related]
12. Combination therapy with low dose sirolimus and tacrolimus is synergistic in preventing spontaneous and recurrent autoimmune diabetes in non-obese diabetic mice. Shapiro AM; Suarez-Pinzon WL; Power R; Rabinovitch A Diabetologia; 2002 Feb; 45(2):224-30. PubMed ID: 11935154 [TBL] [Abstract][Full Text] [Related]
13. Role of ICOS pathway in autoimmune and alloimmune responses in NOD mice. Ansari MJ; Fiorina P; Dada S; Guleria I; Ueno T; Yuan X; Trikudanathan S; Smith RN; Freeman G; Sayegh MH Clin Immunol; 2008 Feb; 126(2):140-7. PubMed ID: 17889619 [TBL] [Abstract][Full Text] [Related]
15. Deletion of STAT-1 pancreatic islets protects against streptozotocin-induced diabetes and early graft failure but not against late rejection. Callewaert HI; Gysemans CA; Ladrière L; D'Hertog W; Hagenbrock J; Overbergh L; Eizirik DL; Mathieu C Diabetes; 2007 Aug; 56(8):2169-73. PubMed ID: 17473223 [TBL] [Abstract][Full Text] [Related]
16. A peptide-major histocompatibility complex II chimera favors survival of pancreatic beta-islets grafted in type 1 diabetic mice. Casares S; Lin M; Zhang N; Teijaro JR; Stoica C; McEvoy R; Farber DL; Bona C; Brumeanu TD Transplantation; 2008 Jun; 85(12):1717-25. PubMed ID: 18580462 [TBL] [Abstract][Full Text] [Related]
17. The effect of transgenic expression of TGF-beta1 on transplanted islet graft survival. Yamasaki S; Kurita N; Hata J; Moritani M; Itakura M; Shimada M Hepatogastroenterology; 2007 Sep; 54(78):1617-21. PubMed ID: 18019678 [TBL] [Abstract][Full Text] [Related]
18. Prevention of recurrent but not spontaneous autoimmune diabetes by transplanted NOD islets adenovirally transduced with immunomodulating molecules. Sakata M; Yasuda H; Moriyama H; Yamada K; Kotani R; Kurohara M; Okumachi Y; Kishi M; Arai T; Hara K; Hamada H; Yokono K; Nagata M Diabetes Res Clin Pract; 2008 Jun; 80(3):352-9. PubMed ID: 18400329 [TBL] [Abstract][Full Text] [Related]
19. Combination therapy with epidermal growth factor and gastrin delays autoimmune diabetes recurrence in nonobese diabetic mice transplanted with syngeneic islets. Suarez-Pinzon WL; Rabinovitch A Transplant Proc; 2008 Mar; 40(2):529-32. PubMed ID: 18374121 [TBL] [Abstract][Full Text] [Related]
20. Gene combination transfer to block autoimmune damage in transplanted islets of Langerhans. Bertera S; Alexander AM; Crawford ML; Papworth G; Watkins SC; Robbins PD; Trucco M Exp Diabesity Res; 2004; 5(3):201-10. PubMed ID: 15512788 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]